Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Breast Cancer

  Free Subscription

Articles published in Oncology

Retrieve available abstracts of 18 articles:
HTML format

Single Articles

    July 2022
  1. CHOI HJ, Lee JH, Jung CS, Lee JE, et al
    Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Oncology. 2022 Jul 26. pii: 000526155. doi: 10.1159/000526155.
    PubMed     Abstract available

    April 2022
  2. NGUYEN V, Chen J, Lord R, Preda V, et al
    The Impact of Multidisciplinary Weight Management on Body Weight and Body Mass Composition in Women with Breast Cancer Post-Adjuvant Chemotherapy: A Retrospective Chart Review.
    Oncology. 2022 Apr 11. pii: 000524519. doi: 10.1159/000524519.
    PubMed     Abstract available

    March 2022
  3. SHIKDAR S, Hall S, Taylor B, de Los Angeles J, et al
    Evaluating the Response of Palbociclib on Progression Free Survival in Hormone Receptor Positive Metastatic Breast Cancer.
    Oncology. 2022 Mar 28. pii: 000524340. doi: 10.1159/000524340.
    PubMed     Abstract available

  4. CHAUHAN D, Geetika, Kumar S, Kumar R, et al
    Combined Interaction of Cellular and Extracellular Components Causes Genetic Cascade Activation in Breast Cancer Metastasis.
    Oncology. 2022 Mar 25. pii: 000524302. doi: 10.1159/000524302.
    PubMed     Abstract available

    February 2022
  5. FUJITA N, Fujita K, Kim SJ, Iguchi C, et al
    Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-up of Prognostic Study Using Propensity Score Matching.
    Oncology. 2022 Feb 3. pii: 000522384. doi: 10.1159/000522384.
    PubMed     Abstract available

    January 2022
  6. BILGILIER C, Fureder T, Kastner MT, Vass Z, et al
    Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
    Oncology. 2022 Jan 20. pii: 000522070. doi: 10.1159/000522070.
    PubMed     Abstract available

    December 2021
  7. FABI A, Ciccarese M, Scagnoli S, Russillo M, et al
    Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
    Oncology. 2021 Dec 7. pii: 000521252. doi: 10.1159/000521252.
    PubMed     Abstract available

  8. YAMAGUCHI K, Matsunuma R, Hayami R, Tsuneizumi M, et al
    Comparison of the Modified IHC4 Score and 21-Gene Recurrence Score Assay in Patients with Estrogen Receptor-Positive Breast Cancer.
    Oncology. 2021 Dec 7. pii: 000521287. doi: 10.1159/000521287.
    PubMed     Abstract available

    September 2021
  9. DE GREGORIO A, Friedl TWP, Hering E, Widschwendter P, et al
    Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
    Oncology. 2021 Sep 14:1-10. doi: 10.1159/000517490.
    PubMed     Abstract available

  10. LAYTRAGOON LEWIN N, Oliva D, Nilsson M, Andersson BA, et al
    Survival Time among Young and Old Breast Cancer Patients in Relation to Circulating Blood-Based Biomarkers, Acute Radiation Skin Reactions, and Tumour Recurrence.
    Oncology. 2021 Sep 3:1-7. doi: 10.1159/000518184.
    PubMed     Abstract available

    August 2021
  11. YARIV O, Mutai R, Rotem O, Tsoref D, et al
    The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer.
    Oncology. 2021 Aug 27:1-9. doi: 10.1159/000518183.
    PubMed     Abstract available

  12. BERGER NF, Zimmerman BS, Tharakan S, Suchman K, et al
    Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and >/=31.
    Oncology. 2021 Aug 23:1-4. doi: 10.1159/000517843.
    PubMed     Abstract available

    June 2021
  13. PAIK HJ, Jung YJ, Kim DI, Lee S, et al
    Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.
    Oncology. 2021 Jun 7:1-8. doi: 10.1159/000515790.
    PubMed     Abstract available

    March 2021
  14. MONTAGNA G, Tong Y, Ritter M, Levi J, et al
    Predictors of Nodal Pathological Complete Response in Asian Women with Stage II-III Node-Positive Breast Cancer.
    Oncology. 2021 Mar 18:1-6. doi: 10.1159/000513454.
    PubMed     Abstract available

  15. MADEKIVI V, Karlsson A, Bostrom P, Salminen E, et al
    Are Breast Cancer Nomograms Still Valid to Predict the Need for Axillary Dissection?
    Oncology. 2021 Mar 10:1-5. doi: 10.1159/000514616.
    PubMed     Abstract available

  16. ZIMMERMAN BS, Seidman D, Cascetta KP, Ru M, et al
    Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
    Oncology. 2021 Mar 2:1-12. doi: 10.1159/000512212.
    PubMed     Abstract available

    January 2021
  17. BATCHU S, Liu F, Amireh A, Waller J, et al
    A Review of Applications of Machine Learning in Mammography and Future Challenges.
    Oncology. 2021;99:483-490.
    PubMed     Abstract available

    September 2020
  18. BORREANI C, Alfieri S, Infante G, Miceli R, et al
    Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
    Oncology. 2020 Sep 29:1-12. doi: 10.1159/000509651.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.